Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Liquidia Corp | CFO and COO | Common Stock | 396K | $5.38M | $13.57 | Apr 14, 2025 | Direct |
Liquidia Corp | CFO and COO | Performance Stock Units | 113K | $1.33M | $11.78 | Jan 11, 2025 | Direct |
Liquidia Corp | CFO and COO | Restricted Stock Unit | 16.4K | $239K | $14.55 | May 31, 2024 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 55.8K | $147K | $2.64 | Jan 31, 2025 | Direct |
Liquidia Corp | CFO and COO | Restricted Stock Unit | 9.38K | $145K | $15.45 | Feb 28, 2025 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 35.9K | $62.1K | $1.73 | Jan 31, 2025 | Direct |
ALIMERA SCIENCES INC | Director | Stock Option (Right to Buy) | 0 | Sep 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LQDA | Liquidia Corp | Apr 14, 2025 | 1 | -$112K | 4 | Apr 16, 2025 | CFO and COO |
LQDA | Liquidia Corp | Feb 28, 2025 | 3 | -$13.5K | 4 | Mar 4, 2025 | CFO and COO |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 31, 2025 | 2 | $0 | 4/A | Feb 4, 2025 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 30, 2025 | 2 | $62.1K | 4 | Feb 3, 2025 | Director |
LQDA | Liquidia Corp | Jan 11, 2025 | 3 | -$275K | 4 | Jan 14, 2025 | CFO and COO |
LQDA | Liquidia Corp | Nov 30, 2024 | 3 | -$12.6K | 4 | Dec 3, 2024 | CFO and COO |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Nov 4, 2024 | 2 | $405K | 4 | Nov 6, 2024 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Nov 4, 2024 | 0 | $0 | 3 | Nov 5, 2024 | Director |
LQDA | Liquidia Corp | Oct 14, 2024 | 1 | -$43.2K | 4 | Oct 15, 2024 | CFO and COO |
ALIM | ALIMERA SCIENCES INC | Sep 16, 2024 | 2 | $0 | 4 | Sep 18, 2024 | Director |
LQDA | Liquidia Corp | Aug 30, 2024 | 3 | -$10.3K | 4 | Sep 4, 2024 | CFO and COO |
LQDA | Liquidia Corp | Jul 12, 2024 | 1 | -$48.9K | 4 | Jul 15, 2024 | CFO and COO |
LQDA | Liquidia Corp | May 31, 2024 | 3 | -$15.9K | 4 | Jun 4, 2024 | CFO and COO |
LQDA | Liquidia Corp | Apr 12, 2024 | 1 | -$45.7K | 4 | Apr 16, 2024 | CFO and COO |
LQDA | Liquidia Corp | Mar 19, 2024 | 4 | -$192K | 4 | Mar 19, 2024 | CFO and COO |
LQDA | Liquidia Corp | Jan 11, 2024 | 3 | $0 | 4 | Jan 16, 2024 | CFO and COO |
LQDA | Liquidia Corp | Nov 30, 2023 | 2 | $0 | 4 | Dec 5, 2023 | Chief Financial Officer |
ALIM | ALIMERA SCIENCES INC | Oct 2, 2023 | 1 | $0 | 4 | Oct 4, 2023 | Director |
LQDA | Liquidia Corp | Aug 31, 2023 | 2 | $0 | 4 | Sep 5, 2023 | Chief Financial Officer |
LQDA | Liquidia Corp | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Chief Financial Officer |
ALIM | ALIMERA SCIENCES INC | Mar 26, 2023 | 1 | $0 | 4 | Mar 28, 2023 | Director |
ALIM | ALIMERA SCIENCES INC | Mar 24, 2023 | 0 | $0 | 3 | Mar 28, 2023 | Director |
LQDA | Liquidia Corp | Feb 28, 2023 | 2 | $0 | 4 | Mar 2, 2023 | Chief Financial Officer |
LQDA | Liquidia Corp | Jan 11, 2023 | 2 | $0 | 4 | Jan 13, 2023 | Chief Financial Officer |
LQDA | Liquidia Corp | Sep 13, 2022 | 1 | $47.9K | 4 | Sep 14, 2022 | Chief Financial Officer |
LQDA | Liquidia Corp | Aug 31, 2022 | 1 | $9.45K | 4/A | Apr 10, 2023 | Chief Financial Officer |
LQDA | Liquidia Corp | Jul 28, 2022 | 1 | $0 | 4 | Aug 1, 2022 | Chief Financial Officer |
LQDA | Liquidia Corp | May 31, 2022 | 2 | $74.9K | 4 | Jun 1, 2022 | Chief Financial Officer |
LQDA | Liquidia Corp | Jan 16, 2022 | 2 | $0 | 4 | Jan 19, 2022 | Chief Financial Officer |
LQDA | Liquidia Corp | Nov 10, 2021 | 2 | $0 | 4 | Nov 12, 2021 | Chief Financial Officer |
LQDA | Liquidia Corp | Jul 21, 2021 | 1 | $0 | 4 | Jul 23, 2021 | Chief Financial Officer |